Reuters -- Drug maker AstraZeneca has agreed to pay $520 million to settle a federal investigation into its marketing practices for the antipsychotic drug Seroquel, the New York Times reported on its website on Monday.
Reuters -- Drug maker AstraZeneca has agreed to pay $520 million to settle a federal investigation into its marketing practices for the antipsychotic drug Seroquel, the New York Times reported on its website on Monday.
